Deutsche Bank Aktiengesellschaft Has Lowered Expectations for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CME) had its target price lowered by investment analysts at Deutsche Bank Aktiengesellschaft from $276.00 to $266.00 in a research report issued on Thursday,MarketScreener reports. The brokerage currently has a “hold” rating on the financial services provider’s stock. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential downside of 2.01% from the stock’s previous close.

A number of other research firms have also weighed in on CME. Morgan Stanley increased their price objective on shares of CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 1st. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research note on Wednesday. Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and upped their target price for the stock from $275.00 to $300.00 in a research note on Thursday, September 25th. Barclays dropped their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Finally, Oppenheimer upped their target price on shares of CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research note on Thursday, July 24th. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $281.00.

CME Group Stock Performance

CME Group stock opened at $271.45 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group has a 1-year low of $213.94 and a 1-year high of $290.79. The firm has a market capitalization of $97.83 billion, a P/E ratio of 26.28, a price-to-earnings-growth ratio of 5.67 and a beta of 0.41. The company’s 50-day moving average is $268.89 and its 200 day moving average is $271.17.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the company posted $2.56 EPS. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Research analysts forecast that CME Group will post 10.49 EPS for the current year.

Insider Buying and Selling at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 in the last ninety days. Company insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

Several institutional investors have recently bought and sold shares of the company. CWC Advisors LLC. boosted its stake in CME Group by 3.1% in the third quarter. CWC Advisors LLC. now owns 4,871 shares of the financial services provider’s stock valued at $1,316,000 after acquiring an additional 146 shares in the last quarter. Sarasin & Partners LLP boosted its stake in CME Group by 10.9% in the third quarter. Sarasin & Partners LLP now owns 1,125,245 shares of the financial services provider’s stock valued at $306,337,000 after acquiring an additional 110,373 shares in the last quarter. Trust Point Inc. acquired a new stake in CME Group in the third quarter valued at approximately $245,000. Natural Investments LLC boosted its stake in CME Group by 5.8% in the third quarter. Natural Investments LLC now owns 1,391 shares of the financial services provider’s stock valued at $375,000 after acquiring an additional 76 shares in the last quarter. Finally, Viking Fund Management LLC boosted its stake in CME Group by 68.0% in the third quarter. Viking Fund Management LLC now owns 42,000 shares of the financial services provider’s stock valued at $11,348,000 after acquiring an additional 17,000 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.